Terms: = Pancreatic cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394
17 results:
1. Cyclotheonellazoles D-I, Potent Elastase Inhibitory Thiazole-Containing Cyclic Peptides from
Holland DC; Schroder WA; Calcott MJ; Kaemmerer E; Avery VM; Ekins MG; Carroll AR
J Nat Prod; 2023 Sep; 86(9):2216-2227. PubMed ID: 37609780
[TBL] [Abstract] [Full Text] [Related]
2. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
Shimura Y; Komatsu S; Nagatani Y; Funakoshi Y; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yanagimoto H; Toyama H; Minami H; Fukumoto T
Ann Surg Oncol; 2023 Oct; 30(11):6603-6610. PubMed ID: 37386304
[TBL] [Abstract] [Full Text] [Related]
3. Genetic characteristics and clinical-specific survival prediction in elderly patients with gallbladder cancer: a genetic and population-based study.
Zhou H; Chen J; Jin H; Liu K
Front Endocrinol (Lausanne); 2023; 14():1159235. PubMed ID: 37152947
[TBL] [Abstract] [Full Text] [Related]
4. Ratio of CA19-9 Level to Total Tumor Volume as a Prognostic Predictor of pancreatic Carcinoma After Curative Resection.
Xu J; Lyu S; Zhao Y; Zhang X; Liu Z; Zhao X; He Q
Technol Cancer Res Treat; 2022; 21():15330338221078438. PubMed ID: 35138217
[No Abstract] [Full Text] [Related]
5. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
[TBL] [Abstract] [Full Text] [Related]
6. A systematic review and network meta-analysis of different surgical approaches for pancreaticoduodenectomy.
Kamarajah SK; Bundred JR; Marc OS; Jiao LR; Hilal MA; Manas DM; White SA
HPB (Oxford); 2020 Mar; 22(3):329-339. PubMed ID: 31676255
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study.
Huang L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Zadnik V; Primic-Žakelj M; Mägi M; Grützmann R; Besselink MG; Schrotz-King P; Brenner H; Jansen L
BMC Med; 2019 Mar; 17(1):66. PubMed ID: 30905320
[TBL] [Abstract] [Full Text] [Related]
8. Is omission of free text records a possible source of data loss and bias in Clinical Practice Research Datalink studies? A case-control study.
Price SJ; Stapley SA; Shephard E; Barraclough K; Hamilton WT
BMJ Open; 2016 May; 6(5):e011664. PubMed ID: 27178981
[TBL] [Abstract] [Full Text] [Related]
9. Correlation of Histological Vessel Characteristics and Diffusion-Weighted Imaging Intravoxel Incoherent Motion-Derived Parameters in pancreatic Ductal Adenocarcinomas and pancreatic Neuroendocrine Tumors.
Klau M; Mayer P; Bergmann F; Maier-Hein K; Hase J; Hackert T; Kauczor HU; Grenacher L; Stieltjes B
Invest Radiol; 2015 Nov; 50(11):792-7. PubMed ID: 26186280
[TBL] [Abstract] [Full Text] [Related]
10. Enhanced antitumor efficacy of ultrasonic cavitation with up-sized microbubbles in pancreatic cancer.
Huang P; Zhang Y; Chen J; Shentu W; Sun Y; Yang Z; Liang T; Chen S; Pu Z
Oncotarget; 2015 Aug; 6(24):20241-51. PubMed ID: 26036312
[TBL] [Abstract] [Full Text] [Related]
11. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.
Kalra S; Atkinson BJ; Matrana MR; Matin SF; Wood CG; Karam JA; Tamboli P; Sircar K; Rao P; Corn PG; Tannir NM; Jonasch E
BJU Int; 2016 May; 117(5):761-5. PubMed ID: 26032863
[TBL] [Abstract] [Full Text] [Related]
12. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.
Massironi S; Conte D; Sciola V; Spampatti MP; Ciafardini C; Valenti L; Rossi RE; Peracchi M
Am J Gastroenterol; 2010 Sep; 105(9):2072-8. PubMed ID: 20372113
[TBL] [Abstract] [Full Text] [Related]
13. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database.
Toso C; Asthana S; Bigam DL; Shapiro AM; Kneteman NM
Hepatology; 2009 Mar; 49(3):832-8. PubMed ID: 19152426
[TBL] [Abstract] [Full Text] [Related]
14. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma.
Toso C; Trotter J; Wei A; Bigam DL; Shah S; Lancaster J; Grant DR; Greig PD; Shapiro AM; Kneteman NM
Liver Transpl; 2008 Aug; 14(8):1107-15. PubMed ID: 18668667
[TBL] [Abstract] [Full Text] [Related]
15. TT virus infection and pancreatic cancer: relationship or accidental coexistence.
Tomasiewicz K; Modrzewska R; Lyczak A; Krawczuk G
World J Gastroenterol; 2005 May; 11(18):2847-9. PubMed ID: 15884138
[TBL] [Abstract] [Full Text] [Related]
16. Serum DU-PAN-2 in the differential diagnosis of pancreatic cancer: influence of jaundice and liver dysfunction.
Fabris C; Malesci A; Basso D; Bonato C; Del Favero G; Tacconi M; Meggiato T; Fogar P; Panozzo MP; Ferrara C
Br J Cancer; 1991 Mar; 63(3):451-3. PubMed ID: 2003987
[TBL] [Abstract] [Full Text] [Related]
17. Somatostatinoma: a case report and review of the literature.
Harris GJ; Tio F; Cruz AB
J Surg Oncol; 1987 Sep; 36(1):8-16. PubMed ID: 3041116
[TBL] [Abstract] [Full Text] [Related]
